Online citations, reference lists, and bibliographies.
← Back to Search

Enzyme Delivery Using The 30Kc19 Protein And Human Serum Albumin Nanoparticles.

Hong Jai Lee, Hee Ho Park, J. Kim, J. Park, Jina Ryu, Jeongseon Choi, J. Lee, W. J. Rhee, T. Park
Published 2014 · Medicine, Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanoparticles have been widely used for delivering various chemical and biomolecular drugs, such as anti-cancer drugs and therapeutic proteins. Among nanoparticles, protein nanoparticles have advantages of non-cytotoxicity and biodegradability. In this study, a recombinant 30Kc19 protein was applied to human serum albumin (HSA) nanoparticles to enhance cellular uptake and stability of a nanoparticle cargo enzyme. The 30Kc19 protein, which originates from silkworm, has cell-penetrating and enzyme-stabilizing abilities. Therefore, 30Kc19-HSA nanoparticles were expected to enhance cellular uptake and stability of an enzyme loaded on the nanoparticles. Here, nanoparticles loaded with β-galactosidase were prepared using the desolvation method. The 30Kc19-HSA nanoparticles were uniformly spherical in shape, dispersed evenly in phosphate buffered saline and cell culture media, and released β-galactosidase in a sustained manner. The 30Kc19-HSA nanoparticles had negligible toxicity to animal cells and exhibited enhanced cellular uptake and intracellular stability of β-galactosidase in HeLa and HEK293 cells when compared with those of HSA nanoparticles. These results suggest that 30Kc19-HSA protein nanoparticles could be used as a versatile tool for drug delivery to various cells.
This paper references
10.1158/1078-0432.CCR-07-1441
Therapeutic Nanoparticles for Drug Delivery in Cancer
Kwangjae Cho (2008)
10.1016/S0006-291X(03)01425-6
Inhibition of apoptosis by recombinant 30K protein originating from silkworm hemolymph.
E. H. Kim (2003)
10.1021/bp990093s
Kinetic Effect of Silkworm Hemolymph on the Delayed Host Cell Death in an Insect Cell‐Baculovirus System
Won Jong Rhee (1999)
10.1002/BIT.20550
Beneficial effect of silkworm hemolymph on a CHO cell system: Inhibition of apoptosis and increase of EPO production.
S. Choi (2005)
10.1152/AJPHEART.1992.262.1.H246
gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis.
J. Schnitzer (1992)
10.1021/BC050146T
Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione.
S. Kommareddy (2005)
Crystal structure of the 30K protein from the silkworm Bombyx mori reveals a new member of the Î2-trefoil superfamily
Jie-Pin Yang (2011)
10.2174/1389557053175335
Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs.
J. M. Irache (2005)
10.1016/j.biomaterials.2012.08.063
A protein delivery system using 30Kc19 cell-penetrating protein originating from silkworm.
J. Park (2012)
10.1016/J.PROCBIO.2011.10.022
Stabilization of enzymes by the recombinant 30Kc19 protein
J. Park (2012)
10.1074/JBC.M006951200
Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway.
V. Rybin (2000)
10.1016/J.IJPHARM.2007.06.028
Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
K. Langer (2008)
10.1126/SCIENCE.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.1002/bit.23091
Enhancement of recombinant human EPO production and sialylation in chinese hamster ovary cells through Bombyx mori 30Kc19 gene expression
Zesong Wang (2011)
10.1021/bp034130y
Inhibition of Apoptosis by a Bombyx mori Gene
E. H. Kim (2004)
10.1006/BBRC.2000.2592
Silkworm hemolymph inhibits baculovirus-induced insect cell apoptosis.
W. J. Rhee (2000)
10.1016/j.jsb.2011.04.003
Crystal structure of the 30 K protein from the silkworm Bombyx mori reveals a new member of the β-trefoil superfamily.
Jie-Pin Yang (2011)
Nano and microparticles as controlled drug delivery devices.
M. N. R. Ravi Kumar (2000)
10.1007/BF00174223
Silkworm hemolymph as a substitute for fetal bovine serum in insect cell culture
S. Ha (1996)
10.1016/j.jconrel.2009.03.002
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
Anja Zensi (2009)
10.1194/JLR.M200449-JLR200
Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200449-JLR200
Libo Wang (2003)
10.1021/bm700535p
Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells.
Oshrat Harush-Frenkel (2008)
10.1016/S0378-5173(03)00134-0
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
K. Langer (2003)
10.1517/14712598.8.8.1063
Biofunctionalized targeted nanoparticles for therapeutic applications.
A. Wang (2008)
10.3109/02652048.2011.635218
Albumin nanoparticles with predictable size by desolvation procedure
B. von Storp (2012)
10.1023/A:1018484309194
Efficient production of recombinant protein in Spodoptera frugiperda/AcNPV system utilizing silkworm hemolymph
S. Ha (2004)
10.1016/J.IJPHARM.2006.03.052
Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.
S. Azarmi (2006)
10.1007/s00253-012-4203-0
Enhancement of recombinant human EPO production and glycosylation in serum-free suspension culture of CHO cells through expression and supplementation of 30Kc19
J. Park (2012)
10.1016/j.jconrel.2011.07.031
Albumin-based nanoparticles as potential controlled release drug delivery systems.
Ahmed O Elzoghby (2012)
10.1016/S0006-291X(02)00746-5
Silkworm hemolymph as a potent inhibitor of apoptosis in Sf9 cells.
W. J. Rhee (2002)
10.1002/BIT.21023
Enhancement of recombinant protein production in Chinese hamster ovary cells through anti‐apoptosis engineering using 30Kc6 gene
S. Choi (2006)
10.1016/S0378-5173(99)00370-1
Desolvation process and surface characterisation of protein nanoparticles.
C. Weber (2000)



This paper is referenced by
10.1002/smll.201500550
Photosensitizer-Conjugated Albumin-Polypyrrole Nanoparticles for Imaging-Guided In Vivo Photodynamic/Photothermal Therapy.
Xuejiao Song (2015)
10.1016/J.JDDST.2017.06.018
Advances on the formulation of proteins using nanotechnologies
Irene Santalices (2017)
10.1002/9781118942246.CH5.4
Bionanocomposite Materials for Biocatalytic Applications
Sarah Christoph (2017)
10.1039/c4bm00230j
Polymeric 3D nano-architectures for transport and delivery of therapeutically relevant biomacromolecules.
G. Gunkel-Grabole (2015)
10.1080/17425247.2016.1193149
Albumin nanostructures as advanced drug delivery systems
Mahdi Karimi (2016)
10.1016/j.biocel.2020.105717
Protein-based direct reprogramming of fibroblasts to neuronal cells using 30Kc19 protein and transcription factor Ascl1.
Jina Ryu (2020)
10.1007/S12668-015-0169-6
Fabrication of Cress Seed Gum Nanoparticles, an Anionic Polysaccharide, Using Desolvation Technique: an Optimization Study
Afsaneh Taheri (2015)
10.1016/bs.irn.2017.08.006
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders.
J. Duskey (2017)
10.1002/biot.201600040
Protein‐stabilizing and cell‐penetrating properties of α‐helix domain of 30Kc19 protein
Jina Ryu (2016)
10.1007/s00253-015-7199-4
Soluble expression and stability enhancement of transcription factors using 30Kc19 cell-penetrating protein
Jina Ryu (2015)
10.3390/nano9050797
Facile and Controllable Fabrication of Protein-Only Nanoparticles through Photo-Induced Crosslinking of Albumin and Their Application as DOX Carriers
Xiangyu Long (2019)
10.1007/s12257-018-0285-6
Exploring Binding Mechanisms between Curcumin and Silkworm 30Kc19 Protein Using Spectroscopic Analyses and Computational Simulations
Md. Abdur Razzak (2018)
10.1016/j.colsurfb.2019.01.065
Fluorescent protein nanoparticles: Synthesis and recognition of cellular oxidation damage.
Bingqiong Yu (2019)
10.1557/ADV.2017.358
The Aqueous Two Phase System (ATPS) Deserves Plausible Real-World Modeling for the Structure and Function of Living Cells
K. Tsumoto (2017)
10.1101/746560
Protein-surfactant-polysaccharide nanoparticles increase the catalytic activity of an engineered β-lactamase maltose-activated switch enzyme
J.P. Fuenzalida (2019)
10.1007/s12257-019-0204-5
Efficient Production of Cell-permeable Oct4 Protein Using 30Kc19 Protein Originating from Silkworm
J. Lee (2019)
10.1016/j.enzmictec.2015.02.008
Development of a transparent, non-cytotoxic, silver ion-exchanged glass with antimicrobial activity and low ion elution.
Gyu-In Shim (2015)
10.1039/c5bm00052a
Protein nanoparticles for therapeutic protein delivery.
L. Herrera Estrada (2015)
10.1016/j.gene.2014.05.038
Identification of a functional element in the promoter of the silkworm (Bombyx mori) fat body-specific gene Bmlp3.
Hanfu Xu (2014)
10.1002/(issn)1860-7314
Biotechnology Journal
Mathew M. Jessop (2019)
10.1186/1556-276X-9-351
Comparative studies of salinomycin-loaded nanoparticles prepared by nanoprecipitation and single emulsion method
Q. Wang (2014)
10.1016/J.OPTMAT.2016.01.018
A silica optical fiber doped with yttrium aluminosilicate nanoparticles for supercontinuum generation
Tonglei Cheng (2016)
10.1021/jp5041713
Modeling the interaction of interferon α-1b to bovine serum albumin as a drug delivery system.
Qi Luo (2014)
10.1007/s00253-016-7689-z
α-Galactosidase delivery using 30Kc19-human serum albumin nanoparticles for effective treatment of Fabry disease
Hong Jai Lee (2016)
10.1016/J.PROCBIO.2017.08.021
Enzyme delivery using protein-stabilizing and cell-penetrating 30Kc19α protein nanoparticles
Hee Ho Park (2017)
10.7150/thno.19365
Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery
Fei-Fei An (2017)
10.1016/j.xphs.2015.11.017
Combined Treatment of Tyrosine Kinase Inhibitor-Labeled Gold Nanorod Encapsulated Albumin With Laser Thermal Ablation in a Renal Cell Carcinoma Model.
C. Callaghan (2016)
10.2174/1381612821666150302115411
Recent advances on the development of pharmacotherapeutic agents on the basis of human serum albumin.
F. Liu (2015)
10.1016/j.jddst.2019.101471
Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs
Elmira Karami (2020)
NANO EXPRESS Open Access
J. Lorbeer (2014)
10.1021/acs.biomac.5b01537
PEGylated Albumin-Based Polyion Complex Micelles for Protein Delivery.
Yanyan Jiang (2016)
10.1021/acs.bioconjchem.7b00231
Role of the Protein Corona Derived from Human Plasma in Cellular Interactions between Nanoporous Human Serum Albumin Particles and Endothelial Cells.
M. Zyuzin (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar